The Indian IPO market is buzzing again and Amanta Healthcare has stepped into the spotlight. With SEBI’s nod in June 2025 and the issue opening today, retail investors are keen to know whether this pharma company is worth betting on. Let’s break it down simply..
Important Dates
| Event | Date |
|---|---|
| IPO Opens | 1 September 2025 |
| IPO Closes | 3 September 2025 |
| Allotment Date | 4 September 2025 |
| Refunds / Demat Credit | 5–6 September 2025 |
| Listing Date | 8–9 September 2025 |
Application Details
| Category | Details |
|---|---|
| Price Band | ₹120 – ₹126 per share |
| Issue Size | 1 crore shares (₹126 crore fresh issue) |
| Lot Size | 119 shares per lot |
| Minimum Investment (1 lot=119 shares) | ~ ₹14,994 |
| Maximum Investment (Retail) (13 lots=1547) | ~₹194,922 |
| Minimum Investment (s-HNI) (14 lots=1666) | ~₹2,09,916 |
| Maximum Investment (s-HNI) (66 lots=7854) | ~₹9,89,604 |
| Category | 100% fresh issue (no OFS) |
Financial Metrics
| Metric | Value (FY25) |
|---|---|
| Return on Equity (RoE) | 10.89% |
| Earnings Per Share (EPS) | ₹3.71 |
| Book Value per Share | ₹33.43 |
| P/E Ratio (Pre-IPO) | ~34x (based on upper band) |
| Post IPO P/E | TBD (depends on listing) |
| Price-to-Book Value | ~3.8x (at ₹126) |
| Debt-to-Equity | Data not disclosed |
| GMP (Grey Market Premium) | ₹22–₹25 |
| Expected Listing Price | ₹148–₹151 (≈18–20% gain) |
What works in Amanta’s favour
- Profit growth: PAT jumped to ₹10.5 cr in FY25 from ₹3.6 cr in FY24.
- Specialized niche: Focus on sterile pharma solutions, with plans to expand.
- Healthy grey market buzz: GMP indicates double-digit listing gains.
What investors should watch out for
- High finance costs: A large chunk of EBITDA is consumed by interest.
- Valuation stretch: At nearly 34x earnings, the stock isn’t cheap.
- Single manufacturing site: Any disruption could hit operations hard.
Final verdict
If you’re applying purely for listing gains, Amanta Healthcare looks attractive given the 17–20% GMP premium.
For the long-term, it’s a decent play on India’s healthcare manufacturing sector, but investors should be mindful of valuation and debt concerns. A cautiously positive approach is the way to go.
Amanta healthcare IPO registrar
Check IPO allotment at below link
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
All the best to all the investors.
Keep investing , keep growing.
1 thought on “Amanta Healthcare IPO: Should You Apply?”